Miranda Versloot

881 citations
20 papers · 486 · h-index 10

Impact in

  • Immunology
    • Atherosclerosis and Cardiovascular Diseases
    • Immune cells in cancer
    • Immune Response and Inflammation
  • Cancer Research
    • Cancer, Lipids, and Metabolism

Papers in

  • Immunology 10
    • Atherosclerosis and Cardiovascular Diseases 6
    • Immune cells in cancer 3
    • Immune Response and Inflammation 2
  • Surgery 5
    • Lipoproteins and Cardiovascular Health 5
Co-authors
Erik S.G. Stroes (11 shared papers)Jeffrey Kroon (11 shared papers)Sophie J. Bernelot Moens (4 shared papers)Hein J. Verberne (3 shared papers)Fleur M. van der Valk (3 shared papers)Simone L. Verweij (3 shared papers)Jan Paul Medema (3 shared papers)Dominique P.V. de Kleijn (3 shared papers)
Journals
Atherosclerosis (5 papers)Cell Communication and Signaling (2 papers)Clinical Cancer Research (1 paper)Clinical Epigenetics (1 paper)PLoS ONE (1 paper)
Partner nations
NetherlandsUnited StatesBelgium

In The Last Decade

Miranda Versloot

19 papers receiving 482 citations

Peers

Miranda Versloot
Comparison fields: 5 of 61
  • Immunology 130
  • Cancer Research 61
  • Nephrology 27
  • Oncology 81
  • Surgery 112
Replace Yanjie Xu with:
Yanjie Xu China
S. Takahashi Japan
Yifeng Sun China
Abbey Willcox Australia
Servé Olieslagers Netherlands
Shenglin Ge China
Lin Tong China
Mike W. Zuurman Netherlands
Marlyse A. Debrincat Australia
Surasak Wichaiyo Thailand
Miranda Versloot relative to Yanjie Xu China Yanjie Xu's profile →
Citations per field
00.5×1.5×
Yanjie Xu · 1×
Citations per year

Countries citing papers authored by Miranda Versloot

Since Specialization
Citations

This map shows the geographic impact of Miranda Versloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Versloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Versloot more than expected).

Fields of papers citing papers by Miranda Versloot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Versloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Versloot. The network helps show where Miranda Versloot may publish in the future.

Co-authors

The 25 scholars most cited alongside Miranda Versloot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miranda Versloot Line = papers co-authored together Miranda Versloot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
Circulation Research ·Johan G. Schnitzler, Renate M. Hoogeveen, Lubna Ali, Koen H.M. Prange, Farahnaz Waissi, Michel van Weeghel, Julian C. Bachmann, Miranda Versloot, Matthew J. Borrelli, Calvin Yeang, Dominique P.V. de Kleijn, Riekelt H. Houtkooper, Marlys L. Koschinsky, Menno P.J. de Winther, Albert K. Groen, Joseph L. Witztum, Sotirios Tsimikas, Erik S.G. Stroes, Jeffrey Kroon
2020141
2
Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
Clinical Cancer Research ·Kristel Kemper, Miranda Versloot, Katherine Cameron, Selçuk Çolak, Felipe de Sousa e Melo, Joan H. de Jong, Joanne Bleackley, Louis Vermeulen, Rogier Versteeg, Jan Köster, Jan Paul Medema
201278
3
Arterial and Cellular Inflammation in Patients with CKD
Journal of the American Society of Nephrology ·Sophie J. Bernelot Moens, Simone L. Verweij, Fleur M. van der Valk, Julian C. van Capelleveen, Jeffrey Kroon, Miranda Versloot, Hein J. Verberne, Henk A. Marquering, Raphaël Duivenvoorden, Liffert Vogt, Erik S.G. Stroes
201651
4
CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease
Cardiovascular Research ·Simone L. Verweij, Raphaël Duivenvoorden, Lotte C.A. Stiekema, Nick S. Nurmohamed, Fleur M. van der Valk, Miranda Versloot, Hein J. Verberne, Erik S.G. Stroes, Matthias Nahrendorf, Siroon Bekkering, Sophie J. Bernelot Moens
201747
5
Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation
Arteriosclerosis Thrombosis and Vascular Biology ·Kim E. Dzobo, Arjen J. Cupido, Barend M. Mol, Lotte C.A. Stiekema, Miranda Versloot, Maaike Winkelmeijer, Jorge Peter, Anne-Marije Pennekamp, Stefan R. Havik, Frédéric M. Vaz, Michel van Weeghel, Koen H.M. Prange, Johannes H.M. Levels, Menno P.J. de Winther, Sotirios Tsimikas, Albert K. Groen, Erik S.G. Stroes, Dominique P.V. de Kleijn, Jeffrey Kroon
202434
6
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Clinical Epigenetics ·Sylwia Wasiak, Kim E. Dzobo, Brooke D. Rakai, Yannick Kaiser, Miranda Versloot, Mahnoush Bahjat, Stephanie C. Stotz, Li Fu, Michael Sweeney, Jan O. Johansson, Norman C.W. Wong, Erik S.G. Stroes, Jeffrey Kroon, Ewelina Kulikowski
202032
7
The structure function of the death domain of human IRAK-M
Cell Communication and Signaling ·Jiangfeng Du, Gerry A. F. Nicolaes, Daniëlle Kruijswijk, Miranda Versloot, Tom van der Poll, Cornelis van ′t Veer
201428
8
The TNF family member APRIL promotes colorectal tumorigenesis
Cell Death and Differentiation ·Valeria Lascano, L F Zabalegui, Kate Cameron, Marco Guadagnoli, M Jansen, Maroeska J. Burggraaf, Miranda Versloot, Hans M. Rodermond, Chris van der Loos, Carla Eponina Carvalho-Pinto, Holger Kalthoff, Jan Paul Medema, Michael Hahne
201224
9
Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques
PLoS ONE ·Sophie J. Bernelot Moens, Sander I. van Leuven, Kang H. Zheng, Stefan R. Havik, Miranda Versloot, Leonie M. van Duivenvoorde, Michael Hahne, Erik S.G. Stroes, Dominique Baeten, Anouk A.J. Hamers
201610
10
Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques
Vascular Pharmacology ·Amr Alaarg, Kang H. Zheng, Fleur M. van der Valk, Acarília Eduardo da Silva, Miranda Versloot, Linda C. Quarles van Ufford, Dominik M. Schulte, Gert Storm, Josbert M. Metselaar, Erik S.G. Stroes, Anouk A.J. Hamers
20169
11
Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT
European Journal of Nuclear Medicine and Molecular Imaging ·Simone L. Verweij, Lotte C.A. Stiekema, Ronak Delewi, Kang H. Zheng, Sophie J. Bernelot Moens, Jeffrey Kroon, Charlotte I. Stroes, Miranda Versloot, Jan J. Piek, Hein J. Verberne, Erik S.G. Stroes
20189
12
The Design and Characterization of Receptor-selective APRIL Variants
Journal of Biological Chemistry ·Fiona C. Kimberley, Almer M. van der Sloot, Marco Guadagnoli, Katherine Cameron, Pascal Schneider, J. Arnoud Marquart, Miranda Versloot, Luís Serrano, Jan Paul Medema
20127
13
Targeted liposomal drug delivery to inhibit atherosclerotic plaque inflammation
Atherosclerosis ·Amr Alaarg, Anouk A.J. Hamers, Miranda Versloot, Mark E. Lobatto, Willem J. M. Mulder, Erik S.G. Stroes, G. Storm, Josbert M. Metselaar
20154
14
Cardiovascular risk in ANCA-associated vasculitis: Monocyte phenotyping reveals distinctive signatures between serological subsets
Atherosclerosis ·Yosta Vegting, Katie Hanford, Aldo Jongejan, Gayle Gajadin, Miranda Versloot, Nelly D. van der Bom‐Baylon, Tamara Dekker, E. Lars Penne, Joost W van der Heijden, Eline Houben, Fréderike J. Bemelman, Annette E. Neele, Perry D. Moerland, Liffert Vogt, Jeffrey Kroon, Marc Hilhorst
20243
15
Protocol to generate a 3D atherogenesis-on-chip model for studying endothelial-macrophage crosstalk in atherogenesis
STAR Protocols ·(unknown), Kim E. Dzobo, Miranda Versloot, Jorge Peter, Jeffrey Kroon
20252
16
The structure function of the death domain of human IRAK-M
Cell Communication and Signaling ·Jiangfeng Du, Gerry A. F. Nicolaes, Daniëlle Kruijswijk, Miranda Versloot, Tom van der Poll, Cornelis van ′t Veer
20142
17
Atherogenic lipoprotein(A) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation
Atherosclerosis ·J.G. Schnitzler, Renate M. Hoogeveen, L. Ali, Koen H.M. Prange, Michel van Weeghel, Miranda Versloot, Farahnaz Waissi, Riekelt H. Houtkooper, Dominique P.V. de Kleijn, Menno P.J. de Winther, Marlys L. Koschinsky, Sotirios Tsimikas, J L Witztum, Erik S.G. Stroes, Jeffrey Kroon
20202
18
Low Hdl-Cholesterol Levels Are Associated With A Decreased Monocyte Activity And Inflammation In Carriers Of Lcat Mutation
Atherosclerosis ·Chiara Pavanello, Kang H. Zheng, J.G. Schnitzler, Jeffrey Kroon, Miranda Versloot, J.H.M. Levels, Laura Calabresi, Erik S.G. Stroes, Siroon Bekkering
20192
19
Targeting lipoprotein(A)-induced endothelial cell metabolic changes in order to reduce inflammation, leukocyte extravasation and thereby atherosclerosis
Atherosclerosis ·J.G. Schnitzler, Renate M. Hoogeveen, Ioana Nicorescu, Miranda Versloot, E.S.G. Stroes, Jeffrey Kroon
20181
20
Inherited Dyslipidemic Splenomegaly: A Genetic Macrophage Storage Disorder Caused by Disruptive Apolipoprotein E (APOE) Variants
Genes ·Elise A. Ferreira, Machteld M. Oud, Saskia N. van der Crabben, Miranda Versloot, Susan Goorden, Clara van Karnebeek, Jeffrey Kroon, Mirjam Langeveld
20250

About Miranda Versloot

Miranda Versloot is a scholar working on Immunology, Surgery, Oncology, Cancer Research and Molecular Biology, having authored 20 papers that have together received 486 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Cancer, Lipids, and Metabolism (3 papers), Immune cells in cancer (3 papers), Cell Adhesion Molecules Research (2 papers), Immune Response and Inflammation (2 papers) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Immunology (130 citations), Cancer Research (61 citations), Nephrology (27 citations), Oncology (81 citations) and Surgery (112 citations). Miranda Versloot has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Erik S.G. Stroes, Jeffrey Kroon, Sophie J. Bernelot Moens, Hein J. Verberne, Fleur M. van der Valk, Simone L. Verweij, Jan Paul Medema, Dominique P.V. de Kleijn, Albert K. Groen and Raphaël Duivenvoorden. Their work appears in journals such as Atherosclerosis, Cell Communication and Signaling, Clinical Cancer Research, Clinical Epigenetics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanjie XuBreakdown of academic impact, for papers by S. TakahashiBreakdown of academic impact, for papers by Yifeng SunBreakdown of academic impact, for papers by Abbey WillcoxBreakdown of academic impact, for papers by Servé OlieslagersBreakdown of academic impact, for papers by Shenglin GeBreakdown of academic impact, for papers by Lin TongBreakdown of academic impact, for papers by Mike W. ZuurmanBreakdown of academic impact, for papers by Marlyse A. DebrincatBreakdown of academic impact, for papers by Surasak Wichaiyo